应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SAGE Sage Therapeutics
已收盘 07-02 16:00:00 EDT
10.82
-0.21
-1.90%
盘后
10.82
+0.00
0.00%
16:13 EDT
最高
11.13
最低
10.66
成交量
81.49万
今开
10.85
昨收
11.03
日振幅
4.26%
总市值
6.51亿
流通市值
5.14亿
总股本
6,018万
成交额
883.46万
换手率
1.71%
流通股本
4,752万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-花旗集团、耐克、特斯拉
Reuters · 06-20
美国研究综述-花旗集团、耐克、特斯拉
美国研究综述-花旗集团、耐克、特斯拉
Reuters · 06-20
美国研究综述-花旗集团、耐克、特斯拉
美国研究综述-欧特克、McKesson、Microstrategy
Reuters · 05-29
美国研究综述-欧特克、McKesson、Microstrategy
美国研究综述-欧特克、McKesson、Microstrategy
Reuters · 05-29
美国研究综述-欧特克、McKesson、Microstrategy
SAGE Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要
Reuters · 04-25
SAGE Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要
嗡嗡声--美国股票走势-MSCI、环球人寿、EQT Corp
Reuters · 04-25
嗡嗡声--美国股票走势-MSCI、环球人寿、EQT Corp
加载更多
公司概况
公司名称:
Sage Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司,其使命是开拓解决方案,提供改变生命的大脑健康药物,让每个人都能茁壮成长。除了产后抑郁症商业产品外,该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司,该公司专注于大脑健康,目前他们的目标是两个关键的中枢神经系统受体系统,GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质,通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。
发行价格:
--
{"stockData":{"symbol":"SAGE","market":"US","secType":"STK","nameCN":"Sage Therapeutics","latestPrice":10.82,"timestamp":1719950400000,"preClose":11.03,"halted":0,"volume":814868,"hourTrading":{"tag":"盘后","latestPrice":10.82,"preClose":10.82,"latestTime":"16:13 EDT","volume":36188,"amount":391578.16,"timestamp":1719951219309},"delay":0,"floatShares":47516451,"shares":60182031,"eps":-8.392453,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.21,"latestTime":"07-02 16:00:00 EDT","open":10.85,"high":11.13,"low":10.66,"amount":8834633.437796,"amplitude":0.042611,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.392453,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":1405656000000,"adjPreClose":11.03,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":10.88,"preClose":11.03,"latestTime":"09:29 EDT","volume":1700,"amount":18502.001,"timestamp":1719926999999},"postHourTrading":{"tag":"盘后","latestPrice":10.82,"preClose":10.82,"latestTime":"16:13 EDT","volume":36188,"amount":391578.16,"timestamp":1719951219309},"volumeRatio":0.608279,"impliedVol":1.0459,"impliedVolPercentile":0.9325},"requestUrl":"/m/hq/s/SAGE","defaultTab":"news","newsList":[{"id":"2444597263","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444597263","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444597263?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":" 路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团 :KBW 将目标价从 66 美元上调至 69 美元 * Lennar Corp :Evercore ISI 将目标价从 238 美元下调至 237 美元 * 耐克公司 :巴克莱将目标价从114美元下调至109美元 * 特斯拉 :加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","ENPH","LU2637428348.USD","NKE","IE00BJTD4V19.USD","ET","LU0052756011.USD","LU1974910355.USD","LU2756315664.SGD","BK4561","BK4144","BFH","LU1861558580.USD","BK4592","LU1917777945.USD","BK4207","LU2756315318.SGD","ZIP","BK4590","BK4550","BK4147","LU1303367103.USD","LU2326559502.SGD","BK4551","LU2087621335.USD","BK4099","KBH","BK4504","BK4566","LU0198837287.USD","SAGE","LU1064131342.USD","LU2063271972.USD","IE00BMG7P926.USD","LEN","IE00BWXC8680.SGD","LU2023250504.SGD","NEE","STZ","IE00BD4GTV84.USD","TSLA","C","LU0056508442.USD","INSM","LU0943347566.SGD","LU2098885051.SGD","LU1720051017.SGD","BK4146","BK4527","TSLL"],"gpt_icon":0},{"id":"2444263518","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444263518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444263518?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":" 路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团 :KBW 将目标价从 66 美元上调至 69 美元 * Lennar Corp :Evercore ISI 将目标价从 238 美元下调至 237 美元 * 耐克公司 :巴克莱将目标价从114美元下调至109美元 * 特斯拉 :加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","ZIP","BK4207","LU2756315664.SGD","NEE","BK4550","BFH","BK4592","KBH","NKE","BK4561","LU0052756011.USD","LU0943347566.SGD","BK4551","LU0056508442.USD","LU1303367103.USD","BK4099","C","BK4566","BK4590","LU2087621335.USD","LU2637428348.USD","ENPH","TSLA","LU1917777945.USD","LU1974910355.USD","LU2326559502.SGD","LEN","LU1064131342.USD","IE00BJTD4V19.USD","LU1861558580.USD","LU2063271972.USD","LU0198837287.USD","IE00BWXC8680.SGD","LU2756315318.SGD","BK4147","LU2023250504.SGD","TSLL","LU1668664300.SGD","LU2098885051.SGD","ET","SAGE","IE00BD4GTV84.USD","IE00BMG7P926.USD","LU1720051017.SGD","BK4527","INSM","STZ","BK4504","BK4146"],"gpt_icon":0},{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":" 路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括欧特克、麦科森和微策略。要闻 * 模拟器件公司 :雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc :贝尔德将目标价从296美元下调至289美元 * Cencora Inc :贝雅将目标价从277美元上调至280美元 * McKesson Corp :贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc :Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1978683503.SGD","AKTS","RLJ","SAGE","BK4139","IE00B19Z4B17.USD","CASY","LU0310799852.SGD","PLMR","LYV","UAL","AAL","AGIO","ADI","INSM","NAPA","MSTR","COR","TAP","RSI","BK4130","LU1244550221.USD","BK4528","CAH","MNRO","LU0323240290.USD","LU0006061336.USD","BK4214","STZ","BK4585","CTRE","HRT","IBTX","TKO","DOMO","MYRG","BK4561","PDFS","MNMD","ADSK","IE00B7SZL793.SGD","TGI","LU1642822529.SGD","BAH","BK4588","IKNA","CRVO","CAVA","BK4529","MCK"],"gpt_icon":0},{"id":"2439590142","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590142?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":" 路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括欧特克、麦科森和微策略。要闻 * 模拟器件公司 :雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc :贝尔德将目标价从296美元下调至289美元 * Cencora Inc :贝雅将目标价从277美元上调至280美元 * McKesson Corp :贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc :Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1978683503.SGD","PDFS","CTRE","RLJ","LU1244550221.USD","NAPA","TKO","BAH","TGI","CAVA","AKTS","BK4528","BK4588","UAL","BK4139","LU0323240290.USD","BK4585","ADSK","AAL","BK4561","CRVO","MCK","PLMR","TAP","INSM","IKNA","LU0006061336.USD","CAH","ADI","COR","RSI","MNMD","DOMO","AGIO","MSTR","BK4529","IE00B19Z4B17.USD","MYRG","IBTX","HRT","LYV","BK4130","SAGE","IE00B7SZL793.SGD","MNRO","STZ","BK4214","LU1642822529.SGD","CASY","LU0310799852.SGD"],"gpt_icon":0},{"id":"2430017287","title":"SAGE Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430017287","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430017287?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:56","pubTimestamp":1714057008,"startTime":"0","endTime":"0","summary":" * SAGE Therapeutics Inc 报告了截至3月底的季度调整后每股亏损1.80美元,高于去年同期的每股亏损2.46美元。18位分析师对该季度的平均预期是每股亏损1.65美元。华尔街预期为每股亏损 2.16 美元至 1.26 美元。* SAGE Therapeutics 公司公布的本季度每股收益为亏损 1.80 美元。* SAGE Therapeutics Inc 本季度股价下跌了 25.3%,今年迄今为止下跌了 35.4%。4月25日 - 预测变化 * 过去三个月,分析师的平均盈利预期下降了约 12.8%。华尔街对 SAGE Therapeutics Inc 的 12 个月目标价中位数为 22.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SAGE","BK4139"],"gpt_icon":0},{"id":"2430465869","title":"嗡嗡声--美国股票走势-MSCI、环球人寿、EQT Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2430465869","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430465869?lang=zh_cn&edition=full","pubTime":"2024-04-25 00:16","pubTimestamp":1713975398,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 4月24日 - 纳斯达克指数周三涨幅超过华尔街同行,特斯拉在发布季度财报后领涨超级大盘股,而其他行业乐观的财报也为纳斯达克指数提供了支撑。美东时间11:31,道琼斯工业平均指数 下跌0.35%,报38368.64点。标准普尔500指数 下跌0.15%,报5063.11点;纳斯达克综合指数 上涨0.16%,报15721.85点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEDG","SDOW","ETR","BSX","QQQ","IE00BZ1G4Q59.USD","LU0965509283.SGD","UDOW","QID","NQmain","DOG","VRT","RILY","GOOGL","T","ENPH",".DJI","HUM","META","DXD","SYF","PSQ","WAB",".IXIC","BA","NEM","QLD","HAS","TXN","DJX","NOVA","BG","LU","DDM","MSCI","BIIB","V","AMRX","HLT","SAGE","SQQQ","MAS","GL","RUN","TQQQ","MNQmain","EQT",".SPX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagerx.com","stockEarnings":[{"period":"1week","weight":-0.0458},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.3606},{"period":"6month","weight":-0.491},{"period":"1year","weight":-0.7654},{"period":"ytd","weight":-0.491}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sage Therapeutics, Inc.于2010年4月16号在特拉华州成立。该公司是一家生物制药公司,其使命是开拓解决方案,提供改变生命的大脑健康药物,让每个人都能茁壮成长。除了产后抑郁症商业产品外,该公司还针对临床开发和早期阶段的大脑疾病和障碍。作为一家公司,该公司专注于大脑健康,目前他们的目标是两个关键的中枢神经系统受体系统,GABA和NMDA。GABA受体家族被认为是中枢神经系统中主要的抑制性神经递质,通过激活GABAA受体介导下游的神经和身体功能。谷氨酸受体系统的NMDA型受体是中枢神经系统中的主要兴奋性受体系统。这些系统的功能障碍与广泛的中枢神经系统疾病有关。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038293},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021443},{"month":3,"riseRate":0.4,"avgChangeRate":-0.042022},{"month":4,"riseRate":0.6,"avgChangeRate":0.045083},{"month":5,"riseRate":0.4,"avgChangeRate":-0.009805},{"month":6,"riseRate":0.5,"avgChangeRate":0.012627},{"month":7,"riseRate":0.5,"avgChangeRate":-0.00913},{"month":8,"riseRate":0.7,"avgChangeRate":-0.023774},{"month":9,"riseRate":0.5,"avgChangeRate":-0.026052},{"month":10,"riseRate":0.4,"avgChangeRate":0.025122},{"month":11,"riseRate":0.7,"avgChangeRate":0.072175},{"month":12,"riseRate":0.6,"avgChangeRate":0.05379}],"exchange":"NASDAQ","name":"Sage Therapeutics","nameEN":"Sage Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sage Therapeutics,SAGE,Sage Therapeutics股票,Sage Therapeutics股票老虎,Sage Therapeutics股票老虎国际,Sage Therapeutics行情,Sage Therapeutics股票行情,Sage Therapeutics股价,Sage Therapeutics股市,Sage Therapeutics股票价格,Sage Therapeutics股票交易,Sage Therapeutics股票购买,Sage Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sage Therapeutics(SAGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sage Therapeutics(SAGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}